Pregabalin Sublingual Tablet 150mg (Pregabalin)

Adult dosage

This medication is Pregabalin and is administered orally twice a day without regard to meals; it should be placed on the tongue and swallowed without water once it dissolves. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose of 150 mg per day, can increase to 300 mg per day after 3 to 7 days, and can be increased further to a maximum of 600 mg per day at 7-day intervals. - Central Neuropathic Pain

Children's dosage

There is insufficient safety and efficacy data for children under 12 years and adolescents aged 12-17, so usage is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors; therefore, if there are any changes in mood or behavior during use, medical personnel should be notified immediately. Patients with hypersensitivity to this medication should not take it. Diabetes patients may require dosage adjustments for blood sugar control due to weight gain. If symptoms of angioedema appear, usage should be discontinued immediately. Elderly patients should be cautious of falls or accidents due to dizziness or drowsiness. Blurred vision or changes in vision may occur, and these symptoms may improve upon discontinuation of the medication. If the medication is abruptly stopped, withdrawal symptoms such as insomnia, headache, and anxiety may occur; therefore, it should be gradually reduced in consultation with a doctor. There is a risk of drug abuse, so caution is needed in patients with a history of mental illness or drug abuse. Patients with reduced kidney function may need dosage adjustments. Patients with heart disease should use this medication with particular caution. Taking this medication with other CNS depressants may increase the risk of respiratory depression and other side effects. It is not recommended for use during the early stages of pregnancy due to the risk of fetal malformations unless special circumstances exist; women of childbearing age should use effective contraception. During lactation, the drug may be passed into breast milk, so nursing should be considered for discontinuation or cessation of the medication. Dizziness and drowsiness are common side effects, so driving or operating dangerous machinery after taking the drug should be avoided. Severe skin reactions may rarely occur; if symptoms such as skin rash or swelling appear, medication should be stopped immediately and medical consultation sought. In the case of overdose, symptoms may include confusion, drowsiness, and depression; treatment such as hemodialysis may be required if necessary. Keep this medication out of reach of children, and avoid transferring it to another container.

Serious side effects

Hives, severe swelling (angioedema, facial swelling, swelling around the mouth and upper airway), chest tightness, difficulty breathing, cold sweats, pallor, severe rash accompanied by fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, respiratory distress, asthma attacks, cough with fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headache, seizures, altered consciousness.

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to protect it from air and moisture. It is crucial to maintain storage temperatures between 1 and 30 degrees Celsius to ensure the drug's effectiveness and safety.

Appearance

Pink oval sublingual tablet

Package unit

30 tablets/PTP [10 tablets/PTP x 3], 100 tablets/PTP [10 tablets/PTP x 10]